UniProt ID | ABL1_HUMAN | |
---|---|---|
UniProt AC | P00519 | |
Protein Name | Tyrosine-protein kinase ABL1 | |
Gene Name | ABL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1130 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. Shuttles between the nucleus and cytoplasm depending on environmental signals. Sequestered into the cytoplasm through interaction with 14-3-3 proteins. Localizes to mitochondria in response to oxidativ | |
Protein Description | Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717'. [PubMed: 28428613 ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner. Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (By similarity] | |
Protein Sequence | MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSASCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVLPATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 2) | Myristoylation | - | 10.12 | - | |
16 (in isoform 2) | Phosphorylation | - | 34.23 | 23927012 | |
24 | Phosphorylation | LSSSSSCYLEEALQR CCCCCHHHHHHHHHC | 21.06 | 27642862 | |
43 | Phosphorylation | DFEPQGLSEAARWNS CCCCCCHHHHHHHCC | 31.82 | 26074081 | |
50 | Phosphorylation | SEAARWNSKENLLAG HHHHHHCCCCCCCCC | 34.09 | 17192257 | |
59 | Phosphorylation | ENLLAGPSENDPNLF CCCCCCCCCCCCCCE | 48.38 | 26074081 | |
70 | Phosphorylation | PNLFVALYDFVASGD CCCEEEEEEHHHCCC | 9.52 | 18691976 | |
75 | Phosphorylation | ALYDFVASGDNTLSI EEEEHHHCCCCEEEE | 41.18 | 20068231 | |
79 | Phosphorylation | FVASGDNTLSITKGE HHHCCCCEEEECCCC | 26.99 | 20068231 | |
81 | Phosphorylation | ASGDNTLSITKGEKL HCCCCEEEECCCCEE | 26.61 | 24719451 | |
83 | Phosphorylation | GDNTLSITKGEKLRV CCCEEEECCCCEEEE | 29.62 | 20068231 | |
93 | Phosphorylation | EKLRVLGYNHNGEWC CEEEEEEECCCCCEE | 14.75 | 47733 | |
113 | Phosphorylation | NGQGWVPSNYITPVN CCCCCCCCCCCCCCH | 32.42 | 21945579 | |
115 | Phosphorylation | QGWVPSNYITPVNSL CCCCCCCCCCCCHHH | 15.54 | 21945579 | |
117 | Phosphorylation | WVPSNYITPVNSLEK CCCCCCCCCCHHHCC | 15.72 | 21945579 | |
126 | Phosphorylation | VNSLEKHSWYHGPVS CHHHCCCCCCCCCCC | 40.16 | 21945579 | |
128 | Phosphorylation | SLEKHSWYHGPVSRN HHCCCCCCCCCCCCH | 10.42 | 21945579 | |
133 | Phosphorylation | SWYHGPVSRNAAEYL CCCCCCCCCHHHHHH | 23.97 | 21945579 | |
134 (in isoform 2) | Phosphorylation | - | 36.72 | 16497976 | |
139 | Phosphorylation | VSRNAAEYLLSSGIN CCCHHHHHHHHCCCC | 14.28 | 23917254 | |
142 | Phosphorylation | NAAEYLLSSGINGSF HHHHHHHHCCCCCCE | 24.75 | - | |
154 | Phosphorylation | GSFLVRESESSPGQR CCEEEEECCCCCCCE | 32.01 | 22817900 | |
157 | Phosphorylation | LVRESESSPGQRSIS EEEECCCCCCCEEEE | 29.06 | 28787133 | |
162 | Phosphorylation | ESSPGQRSISLRYEG CCCCCCEEEEEEECC | 14.51 | 29496963 | |
164 | Phosphorylation | SPGQRSISLRYEGRV CCCCEEEEEEECCEE | 14.19 | 29496963 | |
167 | Phosphorylation | QRSISLRYEGRVYHY CEEEEEEECCEEEEE | 28.20 | 23917254 | |
172 | Phosphorylation | LRYEGRVYHYRINTA EEECCEEEEEEEEEC | 7.56 | 24732914 | |
174 | Phosphorylation | YEGRVYHYRINTASD ECCEEEEEEEEECCC | 8.76 | 24732914 | |
178 | Phosphorylation | VYHYRINTASDGKLY EEEEEEEECCCCCEE | 25.76 | 28152594 | |
180 | Phosphorylation | HYRINTASDGKLYVS EEEEEECCCCCEEEC | 44.87 | 24732914 | |
185 | Phosphorylation | TASDGKLYVSSESRF ECCCCCEEECCHHHH | 11.19 | 21082442 | |
187 | Phosphorylation | SDGKLYVSSESRFNT CCCCEEECCHHHHHH | 18.16 | 28152594 | |
188 | Phosphorylation | DGKLYVSSESRFNTL CCCEEECCHHHHHHH | 29.55 | 28442448 | |
190 | Phosphorylation | KLYVSSESRFNTLAE CEEECCHHHHHHHHH | 44.08 | 28442448 | |
204 (in isoform 2) | Phosphorylation | - | 18.50 | 16497976 | |
215 | Phosphorylation | GLITTLHYPAPKRNK CCEEECCCCCCCCCC | 12.28 | 16912036 | |
224 | Phosphorylation | APKRNKPTVYGVSPN CCCCCCCCEEEECCC | 28.15 | 29978859 | |
226 | Phosphorylation | KRNKPTVYGVSPNYD CCCCCCEEEECCCCC | 17.81 | 22322096 | |
229 | Phosphorylation | KPTVYGVSPNYDKWE CCCEEEECCCCCCCC | 11.76 | 30849837 | |
232 | Phosphorylation | VYGVSPNYDKWEMER EEEECCCCCCCCEEE | 23.45 | 22322096 | |
243 | Phosphorylation | EMERTDITMKHKLGG CEEECCCEEEECCCC | 23.99 | - | |
245 (in isoform 2) | Phosphorylation | - | 29.01 | 16497976 | |
251 (in isoform 2) | Phosphorylation | - | 18.75 | 12644574 | |
253 | Phosphorylation | HKLGGGQYGEVYEGV ECCCCCCCCEEECCH | 20.66 | 21082442 | |
257 | Phosphorylation | GGQYGEVYEGVWKKY CCCCCEEECCHHHHE | 11.58 | 21082442 | |
264 | Phosphorylation | YEGVWKKYSLTVAVK ECCHHHHEEEEEEEE | 12.75 | 21082442 | |
265 | Phosphorylation | EGVWKKYSLTVAVKT CCHHHHEEEEEEEEC | 26.83 | 28152594 | |
267 | Phosphorylation | VWKKYSLTVAVKTLK HHHHEEEEEEEECCC | 10.65 | 20068231 | |
272 (in isoform 2) | Phosphorylation | - | 36.14 | 16497976 | |
274 | Acetylation | TVAVKTLKEDTMEVE EEEEECCCCCCHHHH | 59.79 | 19815429 | |
276 (in isoform 2) | Phosphorylation | - | 50.17 | 16497976 | |
283 (in isoform 2) | Phosphorylation | - | 8.16 | 12644574 | |
285 | Ubiquitination | MEVEEFLKEAAVMKE HHHHHHHHHHHHHHH | 51.10 | - | |
306 | Phosphorylation | VQLLGVCTREPPFYI HHHHCEECCCCCEEE | 35.34 | 46157193 | |
312 | Phosphorylation | CTREPPFYIITEFMT ECCCCCEEEEEEHHH | 9.37 | 18775312 | |
320 | Phosphorylation | IITEFMTYGNLLDYL EEEEHHHHHHHHHHH | 7.70 | 9845501 | |
389 | Phosphorylation | FGLSRLMTGDTYTAH HCCCHHCCCCCEECC | 36.18 | 21945579 | |
392 | Phosphorylation | SRLMTGDTYTAHAGA CHHCCCCCEECCCCC | 24.90 | 21945579 | |
393 | Dephosphorylation | RLMTGDTYTAHAGAK HHCCCCCEECCCCCC | 13.48 | 11163214 | |
393 | Phosphorylation | RLMTGDTYTAHAGAK HHCCCCCEECCCCCC | 13.48 | 22322096 | |
394 | Phosphorylation | LMTGDTYTAHAGAKF HCCCCCEECCCCCCC | 17.66 | 21945579 | |
400 | Ubiquitination | YTAHAGAKFPIKWTA EECCCCCCCCCEECC | 51.24 | - | |
406 | Phosphorylation | AKFPIKWTAPESLAY CCCCCEECCCHHHHC | 27.60 | - | |
412 (in isoform 2) | Phosphorylation | - | 18.35 | 15592455 | |
413 | Phosphorylation | TAPESLAYNKFSIKS CCCHHHHCCCCCCCC | 24.95 | 16464493 | |
417 | Phosphorylation | SLAYNKFSIKSDVWA HHHCCCCCCCCHHHH | 30.62 | - | |
446 | Phosphorylation | PYPGIDLSQVYELLE CCCCCCHHHHHHHHH | 17.53 | 8668151 | |
456 | Phosphorylation | YELLEKDYRMERPEG HHHHHHHHCCCCCCC | 23.95 | 7347443 | |
469 | Phosphorylation | EGCPEKVYELMRACW CCCCHHHHHHHHHHH | 17.89 | 12522270 | |
488 (in isoform 2) | Phosphorylation | - | 38.71 | 16464493 | |
512 | Ubiquitination | EVEKELGKQGVRGAV HHHHHHHHCCHHHHH | 57.41 | - | |
532 | Phosphorylation | APELPTKTRTSRRAA CCCCCCCCCHHHHHH | 41.48 | - | |
535 | Phosphorylation | LPTKTRTSRRAAEHR CCCCCCHHHHHHHCC | 19.24 | 20810815 | |
545 | Phosphorylation | AAEHRDTTDVPEMPH HHHCCCCCCCCCCCC | 39.01 | 28555341 | |
559 | Phosphorylation | HSKGQGESDPLDHEP CCCCCCCCCCCCCCC | 51.88 | 23927012 | |
569 | Phosphorylation | LDHEPAVSPLLPRKE CCCCCCCCCCCCCHH | 16.37 | 29255136 | |
597 | Phosphorylation | LLPKDKKTNLFSALI CCCCCCCCCHHHHHH | 42.78 | 69214187 | |
601 | Phosphorylation | DKKTNLFSALIKKKK CCCCCHHHHHHHHHC | 25.90 | 46157163 | |
610 | Phosphorylation | LIKKKKKTAPTPPKR HHHHHCCCCCCCCCC | 46.91 | 37816903 | |
613 | Phosphorylation | KKKKTAPTPPKRSSS HHCCCCCCCCCCCCC | 50.16 | 17192257 | |
618 | Phosphorylation | APTPPKRSSSFREMD CCCCCCCCCCHHHCC | 36.14 | 23401153 | |
619 | Phosphorylation | PTPPKRSSSFREMDG CCCCCCCCCHHHCCC | 37.21 | 23401153 | |
620 | Phosphorylation | TPPKRSSSFREMDGQ CCCCCCCCHHHCCCC | 29.57 | 25159151 | |
642 | Phosphorylation | EEEGRDISNGALAFT CCCCCCCCCCCEEEE | 33.24 | 24667141 | |
649 | Phosphorylation | SNGALAFTPLDTADP CCCCEEEEECCCCCC | 19.82 | 80535829 | |
653 | Phosphorylation | LAFTPLDTADPAKSP EEEEECCCCCCCCCC | 40.41 | 25850435 | |
659 | Phosphorylation | DTADPAKSPKPSNGA CCCCCCCCCCCCCCC | 40.02 | 30631047 | |
663 | Phosphorylation | PAKSPKPSNGAGVPN CCCCCCCCCCCCCCC | 54.76 | 22199227 | |
676 | Phosphorylation | PNGALRESGGSGFRS CCCCCCCCCCCCCCC | 41.86 | 25159151 | |
679 | Phosphorylation | ALRESGGSGFRSPHL CCCCCCCCCCCCCCC | 37.98 | 23401153 | |
683 | Phosphorylation | SGGSGFRSPHLWKKS CCCCCCCCCCCCCCC | 17.89 | 23401153 | |
689 | Methylation | RSPHLWKKSSTLTSS CCCCCCCCCCCCCCC | 37.75 | - | |
690 | Phosphorylation | SPHLWKKSSTLTSSR CCCCCCCCCCCCCCC | 25.48 | 30576142 | |
691 | Phosphorylation | PHLWKKSSTLTSSRL CCCCCCCCCCCCCCC | 35.99 | 26074081 | |
692 | Phosphorylation | HLWKKSSTLTSSRLA CCCCCCCCCCCCCCC | 40.94 | 26074081 | |
694 | Phosphorylation | WKKSSTLTSSRLATG CCCCCCCCCCCCCCC | 25.41 | 23312004 | |
695 | Phosphorylation | KKSSTLTSSRLATGE CCCCCCCCCCCCCCC | 19.30 | 23186163 | |
696 | Phosphorylation | KSSTLTSSRLATGEE CCCCCCCCCCCCCCC | 26.52 | 23312004 | |
700 | Phosphorylation | LTSSRLATGEEEGGG CCCCCCCCCCCCCCC | 50.12 | 12300595 | |
708 | Phosphorylation | GEEEGGGSSSKRFLR CCCCCCCCCHHHHHH | 34.41 | 21815630 | |
709 | Phosphorylation | EEEGGGSSSKRFLRS CCCCCCCCHHHHHHH | 43.06 | 12300613 | |
710 | Phosphorylation | EEGGGSSSKRFLRSC CCCCCCCHHHHHHHC | 29.55 | 30576142 | |
711 | Acetylation | EGGGSSSKRFLRSCS CCCCCCHHHHHHHCC | 49.47 | 16648821 | |
716 | Phosphorylation | SSKRFLRSCSASCVP CHHHHHHHCCCCCCC | 17.99 | 23927012 | |
718 | Phosphorylation | KRFLRSCSASCVPHG HHHHHHCCCCCCCCC | 25.18 | 23401153 | |
720 | Phosphorylation | FLRSCSASCVPHGAK HHHHCCCCCCCCCCC | 10.19 | 23927012 | |
729 | Phosphorylation | VPHGAKDTEWRSVTL CCCCCCCCCCEEEEC | 36.42 | 23312004 | |
730 | Acetylation | PHGAKDTEWRSVTLP CCCCCCCCCEEEECC | 51.53 | 16648821 | |
730 (in isoform 2) | Acetylation | - | 51.53 | - | |
733 | Phosphorylation | AKDTEWRSVTLPRDL CCCCCCEEEECCHHH | 22.11 | 23403867 | |
735 | Phosphorylation | DTEWRSVTLPRDLQS CCCCEEEECCHHHHH | 32.09 | 19643477 | |
743 | Phosphorylation | LPRDLQSTGRQFDSS CCHHHHHHCCCCCCC | 24.35 | 24719451 | |
751 | Phosphorylation | GRQFDSSTFGGHKSE CCCCCCCCCCCCCCC | 30.19 | 23917254 | |
754 (in isoform 2) | Phosphorylation | - | 22.36 | 15696159 | |
759 | Acetylation | FGGHKSEKPALPRKR CCCCCCCCCCCCCCC | 42.56 | 7822139 | |
779 | Phosphorylation | SDQVTRGTVTPPPRL CCCCCCCCCCCCCCH | 20.23 | 23403867 | |
781 | Phosphorylation | QVTRGTVTPPPRLVK CCCCCCCCCCCCHHC | 29.89 | 17192257 | |
804 | Phosphorylation | VFKDIMESSPGSSPP HHHHHHHHCCCCCCC | 25.18 | 25159151 | |
805 | Phosphorylation | FKDIMESSPGSSPPN HHHHHHHCCCCCCCC | 21.70 | 25159151 | |
808 | Phosphorylation | IMESSPGSSPPNLTP HHHHCCCCCCCCCCC | 42.95 | 29255136 | |
809 | Phosphorylation | MESSPGSSPPNLTPK HHHCCCCCCCCCCCC | 50.74 | 29255136 | |
814 | Phosphorylation | GSSPPNLTPKPLRRQ CCCCCCCCCCCCCCC | 35.59 | 29255136 | |
823 | Phosphorylation | KPLRRQVTVAPASGL CCCCCCEEEEECCCC | 11.56 | 26074081 | |
828 | Phosphorylation | QVTVAPASGLPHKEE CEEEEECCCCCCHHH | 39.54 | 18691976 | |
840 | Phosphorylation | KEEAGKGSALGTPAA HHHCCCCCCCCCCCC | 24.65 | 29396449 | |
844 | Phosphorylation | GKGSALGTPAAAEPV CCCCCCCCCCCCCCC | 15.59 | 25159151 | |
852 | Phosphorylation | PAAAEPVTPTSKAGS CCCCCCCCCCCCCCC | 31.40 | 30266825 | |
854 | Phosphorylation | AAEPVTPTSKAGSGA CCCCCCCCCCCCCCC | 33.23 | 29255136 | |
855 | O-linked_Glycosylation | AEPVTPTSKAGSGAP CCCCCCCCCCCCCCC | 23.01 | 30059200 | |
855 | Phosphorylation | AEPVTPTSKAGSGAP CCCCCCCCCCCCCCC | 23.01 | 30266825 | |
859 | Phosphorylation | TPTSKAGSGAPGGTS CCCCCCCCCCCCCCC | 36.32 | 82313401 | |
884 | Phosphorylation | RHKHSSESPGRDKGK HCCCCCCCCCCCCCC | 34.30 | 23099 | |
915 | Phosphorylation | GKAGGKPSQSPSQEA CCCCCCCCCCCCHHH | 46.94 | 22167270 | |
917 | Phosphorylation | AGGKPSQSPSQEAAG CCCCCCCCCCHHHHH | 30.75 | 22167270 | |
919 | Phosphorylation | GKPSQSPSQEAAGEA CCCCCCCCHHHHHHH | 45.99 | 22167270 | |
935 | Phosphorylation | LGAKTKATSLVDAVN HCCCHHHHHHHHHHC | 24.93 | - | |
936 | Phosphorylation | GAKTKATSLVDAVNS CCCHHHHHHHHHHCC | 31.12 | 17192257 | |
943 | Phosphorylation | SLVDAVNSDAAKPSQ HHHHHHCCCCCCCCC | 23.25 | - | |
949 | Phosphorylation | NSDAAKPSQPGEGLK CCCCCCCCCCCCCCC | 48.58 | 21406692 | |
963 | Phosphorylation | KKPVLPATPKPQSAK CCCCCCCCCCCCCCC | 29.88 | 25159151 | |
968 | Phosphorylation | PATPKPQSAKPSGTP CCCCCCCCCCCCCCC | 46.95 | 17081983 | |
977 | Phosphorylation | KPSGTPISPAPVPST CCCCCCCCCCCCCCC | 19.06 | 17192257 | |
989 | Phosphorylation | PSTLPSASSALAGDQ CCCCCCCCHHHCCCC | 22.08 | 18691976 | |
1011 | Phosphorylation | PLISTRVSLRKTRQP HHEECHHCCCCCCCC | 21.11 | 25627689 | |
1044 | Phosphorylation | EALCLAISRNSEQMA HHHHHHHHCCCHHHH | 21.58 | 24719451 | |
1064 | Phosphorylation | LEAGKNLYTFCVSYV HHHHCHHHHHHHHHH | 13.73 | 45559739 | |
1070 | Phosphorylation | LYTFCVSYVDSIQQM HHHHHHHHHHHHHHH | 6.46 | 69101443 | |
1103 | Phosphorylation | ELQICPATAGSGPAA HCEECHHCCCCCCCH | 19.38 | 25262027 | |
1106 | Phosphorylation | ICPATAGSGPAATQD ECHHCCCCCCCHHHH | 38.86 | 62175385 | |
1111 | Phosphorylation | AGSGPAATQDFSKLL CCCCCCHHHHHHHHH | 30.67 | 23917254 | |
1115 | Phosphorylation | PAATQDFSKLLSSVK CCHHHHHHHHHHHHH | 30.59 | 25262027 | |
1119 | Phosphorylation | QDFSKLLSSVKEISD HHHHHHHHHHHHHHH | 43.45 | 24719451 | |
1125 | Phosphorylation | LSSVKEISDIVQR-- HHHHHHHHHHHHC-- | 23.52 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
70 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
70 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
70 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
70 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
89 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
115 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
115 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
115 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
128 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
128 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
128 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
139 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
139 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
139 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
172 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
172 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
172 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
185 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
185 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
185 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
197 | T | Phosphorylation | Kinase | LATS2 | Q9NRM7 | PSP |
215 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
215 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
215 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
226 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
226 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
226 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
226 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
232 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
245 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | GPS |
245 | Y | Phosphorylation | Kinase | HCK | P08631 | GPS |
253 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
257 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
393 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
393 | Y | Phosphorylation | Kinase | SRC-TYPE TYR-KINASES | - | Uniprot |
393 | Y | Phosphorylation | Kinase | SRC-FAMILY | - | GPS |
393 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
393 | Y | Phosphorylation | Kinase | ABL1 | P00519 | PhosphoELM |
393 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
393 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
412 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
412 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | GPS |
412 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
446 | S | Phosphorylation | Kinase | ATM | Q13315 | PhosphoELM |
446 | S | Phosphorylation | Kinase | ATM | Q62388 | PSP |
488 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
618 | S | Phosphorylation | Kinase | PAK2 | Q13177 | Uniprot |
619 | S | Phosphorylation | Kinase | PAK2 | Q13177 | Uniprot |
735 | T | Phosphorylation | Kinase | MAP3K8 | P41279 | GPS |
735 | T | Phosphorylation | Kinase | CLK1 | P49759 | PSP |
735 | T | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
735 | T | Phosphorylation | Kinase | STK4 | Q13043 | GPS |
735 | T | Phosphorylation | Kinase | TTK | P33981 | PSP |
735 | T | Phosphorylation | Kinase | CLK4 | Q9HAZ1 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXL5 | Q9UKA1 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:12475393 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ABL1_HUMAN !! |
Kegg Disease | |
---|---|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
H00004 | Chronic myeloid leukemia (CML) |
OMIM Disease | |
608232 | Leukemia, chronic myeloid (CML) |
Kegg Drug | |
D01441 | Imatinib mesilate (JAN); Imatinib mesylate (USAN); Gleevec (TN); Glivec (TN) |
D03252 | Bosutinib (USAN) |
D03658 | Dasatinib (INN) |
D06413 | Nilotinib hydrochloride hydrate (JAN); Tasigna (TN) |
D06414 | Dasatinib hydrate (JAN); Dasatinib (USAN); Sprycel (TN) |
D08066 | Imatinib (INN); Glamox (TN) |
D08279 | Tozasertib (USAN) |
D08344 | Tozasertib lactate (USAN); MK-0457 |
D08953 | Nilotinib (USAN/INN) |
D09664 | Saracatinib (USAN/INN) |
D09665 | Saracatinib difumarate (USAN) |
D09728 | Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
D09950 | Ponatinib (USAN/INN) |
D09951 | Ponatinib hydrochloride (USAN); Iclusig (TN) |
D10202 | Bafetinib (USAN) |
D10334 | Rebastinib (USAN) |
D10399 | Rebastinib Tosylate (USAN) |
DrugBank | |
DB00171 | Adenosine triphosphate |
DB06616 | Bosutinib |
DB01254 | Dasatinib |
DB00619 | Imatinib |
DB04868 | Nilotinib |
DB08901 | Ponatinib |
DB08896 | Regorafenib |
loading...
Acetylation | |
Reference | PubMed |
"c-Abl acetylation by histone acetyltransferases regulates itsnuclear-cytoplasmic localization."; di Bari M.G., Ciuffini L., Mingardi M., Testi R., Soddu S., Barila D.; EMBO Rep. 7:727-733(2006). Cited for: ACETYLATION AT LYS-711, AND SUBCELLULAR LOCATION. | |
Phosphorylation | |
Reference | PubMed |
"Organization of the SH3-SH2 unit in active and inactive forms of thec-Abl tyrosine kinase."; Nagar B., Hantschel O., Seeliger M., Davies J.M., Weis W.I.,Superti-Furga G., Kuriyan J.; Mol. Cell 21:787-798(2006). Cited for: X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 38-512, MASS SPECTROMETRY,MYRISTOYLATION OF N-TERMINUS (ISOFORM IB), PHOSPHORYLATION AT SER-50,AUTOINHIBITION MECHANISM, AND ENZYME REGULATION. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-569, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-392; TYR-393 ANDSER-569, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-805; SER-809; THR-852AND SER-855, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; THR-844; THR-852AND SER-917, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; TYR-185; TYR-393;SER-569; THR-613; SER-620; SER-659; SER-683; SER-718; THR-781;SER-805; SER-809; THR-814; THR-844; THR-852; SER-917; SER-919; SER-936AND SER-977, AND MASS SPECTROMETRY. | |
"Phosphorylation of c-Abl by protein kinase Pak2 regulatesdifferential binding of ABI2 and CRK."; Jung J.H., Pendergast A.M., Zipfel P.A., Traugh J.A.; Biochemistry 47:1094-1104(2008). Cited for: PHOSPHORYLATION AT SER-618 AND SER-619, AND INTERACTION WITH ABI2 ANDCRK. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; SER-683; SER-805;SER-809 AND SER-949, AND MASS SPECTROMETRY. | |
"JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting ofc-Abl in the apoptotic response to DNA damage."; Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.; Nat. Cell Biol. 7:278-285(2005). Cited for: INTERACTION WITH YWHAB; YWHAE; YWHAG; YWHAH; SFN AND YWHAZ,PHOSPHORYLATION AT THR-735, MASS SPECTROMETRY, SUBCELLULAR LOCATION,AND MUTAGENESIS OF THR-735. | |
"Profiling of tyrosine phosphorylation pathways in human cells usingmass spectrometry."; Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T.,Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C.; Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185; TYR-226; TYR-253;TYR-257; TYR-264; TYR-393; THR-394 AND TYR-469, AND MASS SPECTROMETRY. | |
"Tyrosine phosphorylation in the SH3 domain disrupts negativeregulatory interactions within the c-Abl kinase core."; Chen S., O'Reilly L.P., Smithgall T.E., Engen J.R.; J. Mol. Biol. 383:414-423(2008). Cited for: PHOSPHORYLATION AT TYR-70, AND INTERACTION WITH ABI1. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185, AND MASSSPECTROMETRY. |